Molecular Cloning, Genomic Organization, Promoter Activity, and Tissue-Specific Expression of the Mouse Ryudocan Gene^1

スポンサーリンク

概要

• 論文の詳細を見る
• Japanese Biochemical Societyの論文
• 1997-07-01

著者

• Saito H

  Department Of Hematology Meitetsu Hospital

• Hiraoka Sakamaki

  Department Of Hematology Tokyo Metropolitan Komagome Hospital

• Kojima Tetsuhito

  名古屋市立大学 医学系研究科血液腫瘍内科学

• Katsumi A

  Department Of Hematology-oncology Nagoya University Graduate School Of Medicine

• Katsumi Akira

  名古屋市立大学 医学系研究科血液腫瘍内科学

• Sao Hiroshi

  Department Of Hematology Hamamatsu Medical Center

• KOJIMA Tetsuhito

  First Department of Internal Medicine, Nagoya University School of Medicine

• TSUZUKI Shinobu

  First Department of Internal Medicine, Nagoya University School of Medicine

• KATSUMI Akira

  First Department of Internal Medicine, Nagoya University School of Medicine

• YAMAZAKI Tomio

  First Department of Internal Medicine, Nagoya University School of Medicine

• SUGIURA Isamu

  First Department of Internal Medicine, Nagoya University School of Medicine

• SAITO Hidehiko

  First Department of Internal Medicine, Nagoya University School of Medicine

• Yamazaki Tomio

  Department Of Hemostasis And Thrombosis Clinical Research Center Nagoya Medical Center

• Yamazaki Tomio

  First Department Of Internal Medicine Nagoya University School Of Medicine

• Sugiura Isamu

  First Department Of Internal Medicine Nagoya University School Of Medicine

• Tsuzuki Shinobu

  名古屋大学 第1内科

• Tsuzuki Shinobu

  First Department Of Internal Medicine Nagoya University School Of Medicine

• Saito H

  Nagoya Central Hospital

• Soda Hisashi

  Department Of Hematology Tokyo Metropolitan Komagome Hospital

• Katsumi Akira

  Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine

• Saito Hidehiko

  First Department Of Internal Medicine Nagoya University School Of Medicine

• Yamazaki T

  Department Of Hemostasis And Thrombosis Clinical Research Center Nagoya Medical Center

• Saito H

  Nagoya National Hospital

• Kojima Tetsuhito

  First Department First Department Of Internal Medicine Nagoya University School Of Medicine:departme

• Yamazaki Takashi

  Department Of Life Science Graduate School Of Bioscience And Biotechnology Tokyo Institute Of Techno

関連論文

• A SIMPLE AND SELECTIVE HPLC METHOD FOR THE SIMULTANEOUS DETERMINATION OF PARAQUAT AND DIQUAT IN HUMAN URINE
• Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
• 白血病細胞株を用いた巨核芽球系分化誘導モデルにおけるヒトスフィンゴシンキナーゼ1発現機序の解析
• Long-PCR 法を用いた血液凝固第 VIII 因子 遺伝子の逆位解析
• Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
• Activated protein C resistance in the Japanese population due to homozygosity for the factor V R2 haplotype
• Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
• Successful treatment of relapsed T-cell non-Hodgkin's lymphoma with allogeneic peripheral blood stem cell transplantation with double conditioning
• Monitoring Minimal Residual Disease in Leukemia Using Real-time Quantitative Polymerase Chain Reaction for Wilms Tumor Gene (WT1)
• Expression of the Wilms' Tumor Gene WT1 in Solid Tumors and Its Involvement in Tumor Cell Growth
• Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
• Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia : a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry
• Chronic Graft-versus-Host Disease following Varicella-Zoster Virus Infection in Allogeneic Stem Cell Transplant Recipients
• Stress-induced PAI-1 expression is suppressed by pitavastatin in vivo
• Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
• Definite diagnosis in Japanese patients with protein C deficiency by identification of causative PROC mutations
• Mutational analysis of SOS1 gene in acute myeloid leukemia
• Identification of amino acid residues responsible for von Willebrand factor binding to sulfatide by charged-to-alanine-scanning mutagenesis
• Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
• Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
• Wilms' tumor 1 message and protein expression in bone marrow failure syndrome and acute leukemia
• Mutated RAS Induced PLD1 Gene Expression through Increased Sp1 Trascription Factor
• Recurrent Mutations of Factor XI Gene in Japanese
• Structural Organization and Promoter Activity of the Human Ryudocan Gene
• Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
• シンポジウム3 血栓症への新しいアフローチ血栓症の分子細胞学的基礎-プロテインC, プロテインS欠損症を例として-
• ジーンターゲティングを用いた血液凝固制御因子の生体における機能解明 : マウスantithrombinの完全欠損による胎児死亡とsyndecan-4欠損による胎盤迷路層胎児血管の変性
• Recurrent Intramural Hematoma of the Small Intestine in a Severe Hemophilia A Patient with a High Titer of Factor VIII Inhibitor : A Case Report and Review of the Literature
• High Titer of ADAMTS13 Inhibitor Associated with Thrombotic Microangiopathy of the Gut and Skeletal Muscle after Allogeneic Hematopoietic Stem Cell Transplantation
• Clinical Trial to Investigate the Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Recombinant Factor VIIa in Japanese Patients With Hemophilia With Inhibitors
• Sensitive immunohistochemical detection of WT1 protein in tumors with anti-WT1 antibody against WT1 235 peptide
• High frequencies of less differentiated and more proliferative WT1-specific CD8^+ T Cells in bone marrow in tumor-bearing patients : An important role of bone marrow as a secondary lymphoid organ
• Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
• Biased usage of BV gene families of T-cell receptors of WT1 (Wilms' tumor gene)-specific CD8^+ T cells in patients with myeloid malignancies
• Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor
• Human Herpesvirus 6 Meningoencephalitis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
• Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma
• Individual Dose Adjustment of Oral Busulfan Using a Test Dose in Hematopoietic Stem Cell Transplantation
• Molecular Cloning, Genomic Organization, Promoter Activity, and Tissue-Specific Expression of the Mouse Ryudocan Gene^1
• Analysis for heterozygosity of protein S mRNA: application to genetic screening and family studies in hereditary protein S deficiency
• 教育シンポジウム:がんの遺伝子診断 PCRを用いた遺伝子診断の原理と応用-血友病Bを例にして-
• Interferon-α treatment of acute lymphoblastic leukemia relapse after unrelated bone marrow transplantation
• Granulocyte colony-stimulating factor-combined marrow-ablative chemotherapy and autologous blood cell transplantation for the treatment of patients with acute myelogenous leukemia in first remission
• Long-term Follow-up of 14 Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia following Autologous Bone Marrow Transplantation in First Complete Remission
• A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial
• Impact of Cytogenetics on Outcome of Stem Cell Transplantation for Acute Myeloid Leukemia in First Remission : A Large-Scale Retrospective Analysis of Data from the Japan Society for Hematopoietic Cell Transplantation
• Quality of Life in Adult Patients After Stem Cell Transplantation
• Superior Efficacy of MMCP Regimen Compared with VMCP and MMPP Regimens in the Treatment of Multiple Myeloma
• Posttreatment Nadir M-Protein Level Is a Stronger Discriminator of Survival Following Plateau Attainment Than Is Percent Reduction in M-Protein in Patients With IgG Myeloma
• Molecular remission achieved by interferon therapy in a patient with cytogenetically relapsed chronic myelogenous leukemia after syngeneic bone marrow transplantation
• Clusters of Basic Amino Acids in Midkine: Roles in Neurite-Promoting Activity and Plasminogen Activator-Enhancing Activity^1
• 先天性凝固阻止因子欠乏症(antithrombin, protein C, protein S 欠損症)
• Successful treatment using tacrolimus ointment for cutaneous graft-versus-host disease
• Low-Dose Cyclosporin A with Short-Term Methotrexate for Graft-versus-Host Disease Prophylaxis in Allogeneic Bone Marrow Transplantation from Human Leukocyte Antigen-Identical Siblings : A Prospective Phase II Study in Japanese Patients
• Twenty Years' Experience in Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Nagoya Blood and Marrow Transplantation Group
• Severe hemophilia A in a Japanese female caused by an F8-intron 22 inversion associated with skewed X chromosome inactivation
• Classic Polyarteritis Nodosa Presenting Rare Clinical Manifestations in a Patient with Hemophilia A
• AT/DS併用によるエンドトキシン誘発臓器傷害の改善効果 : Antithrombin/danaparoid sodium の抗凝固薬としての位置付け
• Identification of the regulatory elements of the human von Willebrand factor for binding to platelet GPIb. Importance of structural integrity of the regions flanked by the CYS1272-CYS1458 disulfide bond
• Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions
• Identification of plasma antibody epitopes and gene abnormalities in Japanese hemophilia a patients with factor VIII inhibitor
• Optimization of the Oxidative Folding Reaction and Disulfide Structure Determination of Multiple-Cystine Peptides
• Modifications Associated with Use of the Benzyloxymethyl Group on Histidine
• Chemical Synthesis of Human β-Defensin (hBD)-1,2,3 and 4 : Optimization for Folding Reduced hBDs into a Native Conformation
• Synthesis and Disulfide Structure Determination of Muscarinic Toxin 3
• Synthesis of Amyloid β-Peptides by Employing a Convergent Solid-Phase Approach Performed in a Mixture of Chloroform and Phenol
• Synthesis and Disulfide Structure Determination of Kurtoxin, a T-type Calcium Channel Blocker
• Synthesis of Prokineticin 2 by Solid-Phase Approach Performed in a Chloroform-Phenol Mixed Solvent
• Synthesis of Human Leptin Employing a Combined Solid-Phase and Solution Approach
• Optimization of Segment Condensation Reactions of Sparingly Soluble Protected Peptides in Chloroform-Phenol Mixed Solvent
• Side Reaction Associated with Use of N^in-Cyclohexyloxy- carbonyl (Hoc) Group for Tryptophans during HF Deprotection
• Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1
• Effect of Depolymerized Holothurian Glycosaminoglycan (DHG) on the Activation of Factor VIII and Factor V by Thrombin
• Recovery of Normal Hematopoiesis after Severe Bone Marrow Aplasia Induced by Interferon-α in a Patient with Chronic Myelogenous Leukemia
• Durable Remission by Sobuzoxane in an HIV-Seronegative Patient with Human Herpesvirus 8-Negative Primary Effusion Lymphoma
• Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors
• Overexpression of the Wilms' tumor gene WT1 in primary thyroid cancer
• Overexpression of the Wilms' tumor gene WT1 in human bone and soft-tissue sarcomas
• Wilms Tumor Gene WT1 Peptide-Based Immunotherapy Induced a Minimal Response in a Patient with Advanced Therapy-Resistant Multiple Myeloma
• WT1_, a Ninemer Peptide Derived from Wilms' Tumor Gene Product, Is a Candidate Peptide for the Vaccination of HLA-A^*0201-Positive Patients with Hematopoietic Malignancies
• WT1 Peptide-Based Immunotherapy for Patients with Lung Cancer : Report of Two Cases
• Wilms Tumor Gene Peptide-Based Immunotherapy for Patients with Overt Leulemia from Myelodysplastic Syndrome (MDS) or MDS with Myelofibrosis
• The lck Promoter-Driven Expression of the Wilms Tumor Gene WT1 Blocks Intrathymic Differentiation of T-Lineage Cells
• Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro
• Overexpression of the Wilms' tumor gene WT1 in colorectal adenocarcinoma
• Novel Synthesized Trimannose Conjugate Induces Endocytosis and Expression of Immunostimulatory Molecules in Monocytic Leukemia Cells
• Genetic Abnormalities of Bernard-Soulier Syndrome
• Retrospective study of inhibitor formation in Japanese hemophiliacs
• WT1 (Wilms' Tumor 1) Peptide Immunotherapy for Renal Cell Carcinoma
• Overexpression of the Wilms′tumor gene WT1 in head and neck squamous cell carcinoma
• Early treatment of CMV antigenemia with ganciclovir for prevention of fatal CMV disease in patients receiving marrow from HLA-matched unrelated donors
• Efficient Induction of Pptide - Specific Cytotoxic T Lymphocytes by LPS - Activated Spleen Cells
• Interferon-α and zidovudine for relapsed/refractory adult T cell leukemia/lymphoma : case reports of Japanese patients
• Identification of a WT1 protein-derived peptide, WT1_, : as a HLA-A^*0206-restricted, WT1-specific CTL epitope
• A WT1 protein-derived, naturally processed 16-mer peptide, WT1_, is a promiscuous helper peptide for induction of WT1-specific Th1-type CD4^+ T cells
• Unrelated Bone Marrow Transplantation Induced Long-Term Remission in a Patient with Life-Threatening Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis
• Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
• Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation
• Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
• Successful treatment by donor lymphocyte infusion of adult T-cell leukemia/lymphoma relapse following allogeneic hematopoietic stem cell transplantation

もっと見る 閉じる

スポンサーリンク